Ivan Da Silva

@mvpcastro Elenco do Lanus eh mediocre. Eh vergonha perder pra eles. Nem camisa eles tem.

Lanus campeão com justiça. O que me parece injusto é essa derrota dessa maneira. Hoje, ao contrário da maioria dos jogos desse ano, o Flamengo teve empenho, luta. Mas alguns nomes estão irreconhecíveis. É hora de reconstruir mesmo.

@ChelseaParlett Awesome! Would you mind sharing the YT channels/resources? Thanks

Forgot to mention: some students stopped and asked to pet nova, and said they needed stress relief from their STATS MIDTERM🥹 I gave them a bunch of recommendations for YT channels and other resources 🤩

Visited my old college campus yesterday, and went by the classroom* where I fell in love with statistics, and changed my entire career path 😱 (Nova, as you can see, did not give a single bother)

@nickmmark @NanouTheNomad Or Warfarin: “The name warfarin is derived from WARF (Wisconsin Alumni Research Foundation) and –arin from coumarin”

@NanouTheNomad There’s another antibiotic with a great name/origin. It is named after the little girl (Traci) where the bacteria (B subtilis) that produces it was first isolated. Bacillus subtilis variant Traci Aka Bacitracin

@OakPark This happened displacing and restricting to a very limited space the already existing school, First Baptist Preschool and Kindergarten, that has been serving for decades minorities with very affordable tuitions

School secures First Baptist Church’s school as its new location oakpark.com/2023/06/07/the…

Hot off the press! @AHAScience @American_Heart @American_Stroke Subarachnoid Hemorrhage Guidelines published today in @StrokeAHA_ASA . Clinicians who see patients with SAH will need to read this update to the previous 2012 guidelines: ahajournals.org/doi/10.1161/ST…

@GregLJMU @statsepi If you squeeze in the title terms like “machine learning” or “precision medicine”, your odds of publishing become astronomical

@Richard_D_Riley @GSCollins Awesome!!

@ivanrf @GSCollins It is online 😀 Details here - prognosisresearch.com/training-cours…

Day 3 of our 'Statistical Methods for Risk Prediction & Prognostic Models' course - today we focus on external validation, clinical utility, pseudo observations, meta-analysis & big data, model presentation, and a live lecture from @GSCollins on critical appraisal and reporting

@patricia_yates @incunabula @MosulEye Would you know the name of the documentary? Sounds very interesting

@incunabula @MosulEye Watched the three part documentary on the history of writing. Absolutely fascinating and very,very interesting.

THE INVENTION OF WRITING The Sumerian epic of Enmerkar records the moment: "Because the messenger's mouth was heavy and he couldn't repeat [the message], the Lord of Kulaba patted some clay and put words on it, like a tablet. UNTIL THEN, THERE HAD BEEN NO PUTTING WORDS ON CLAY."

@MaartenvSmeden Excellent paper! BTW, what are the journals you would recommend to follow in the area of epidemiology and biostatistics (focused on clinical medicine). I am no statistician by training (PhD in neuroscience and epidemiology).

TL:DR

New 2-pager intro to clinical prediction modeling is out @JClinEpi Wondering what the key differences are between diagnostic and prognostic modeling (spoiler: not much)? Comes with some hopefully useful pointers for newcomers to the field authors.elsevier.com/a/1coR83BcJQ6%…

@kdpsinghlab @threadreaderapp unroll

In medicine, we take the Hippocratic Oath and promise to do no harm. When applying ML and AI models in healthcare, decision curves can help us decide if a model will do less harm than a treat-all or treat-none (“do no harm”) strategy under an *assumed* cost/benefit ratio. /Fin

Thanks everyone for your votes on each of the scenarios. In this thread, I’ll walk through Scenario 1 — both how I thought about it originally, and how decision curves can help. Let’s get started. Popular opinion was to use neither model. My vote was for Model B. Here’s why.

@RushNeurology @NMNeurology @somedocs @UICneuroscience @JAMANeuro @NeurosurgeryNM @TheNewANA1 @MovementRush @TopNeuroDocs #Neurology #NeuroTwitter Learn more and register: rushneurologyupdate.com

Very excited for another “Brush with Rush”!!

Join us for the Brush with Rush tomorrow!! Dr Szewka will be talking about the Culture of Education at Rush. Register in advance for this meeting: Rush.zoom.us/meeting/regist… Great opportunity to learn more about our neurology residency program! @RushNeurology

Join us tomorrow 10/22 at 3:30PM CDT for the second in our Brush with Rush series! We will be talking to Dr. Szewka, neuro-ophthalmology attending and vice chair of education, about the culture of education in neurology. Register here: rushu.rush.edu/education-and-…

Please join us for A Brush with Rush on 10/7! The first in a series of brief (15-20 min) virtual info sessions to learn more about our program. Recordings will be available on our website to view at your leisure. #NeuroTwitterNetwork #NeuroTwitter #Neurology

Join us for a Brush with Rush! 10/7 at 3:30 pm CST. The first in a series of virtual webinars to learn more about our program. Register @ rush.zoom.us/meeting/regist…. #neurology #NeuroTwitter #NeuroTwitterNetwork

@AlexandreIMPA @rationalexpec @agpatriota @threadreaderapp unroll

@rationalexpec Mais uma vez, agradeço @rationalexpec e @agpatriota pelos comentários e sugestões.

Olá pessoal, vamos continuar agora com a parte 2 da nossa thread sobre testes de hipóteses. Para retomar a thread, vamos começar definindo o que são testes paramétricos, testes não-paramétricos, e fornecendo exemplos.

@f_g_zampieri Welcome to the club 😂

Imposter syndrome hitting hard today

#ObrigadoSenna @heinekenbr